De-escalation of post-treatment surveillance in oropharyngeal cancer.
Ambulatory Care Facilities
/ statistics & numerical data
Cancer Survivors
Carcinoma, Squamous Cell
/ diagnostic imaging
Cohort Studies
Continuity of Patient Care
Female
Finland
Follow-Up Studies
Hospitals, University
Humans
Incidence
Male
Neoplasm Invasiveness
/ pathology
Neoplasm Recurrence, Local
/ diagnostic imaging
Neoplasm Staging
Oropharyngeal Neoplasms
/ diagnostic imaging
Papillomavirus Infections
/ epidemiology
Positron Emission Tomography Computed Tomography
/ methods
Prognosis
Retrospective Studies
Risk Assessment
follow-up
human papillomavirus
oropharyngeal cancer
recurrence
squamous cell carcinoma
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
10
03
2018
revised:
11
09
2018
accepted:
05
12
2018
pubmed:
26
12
2018
medline:
24
11
2020
entrez:
25
12
2018
Statut:
ppublish
Résumé
The majority of new oropharyngeal squamous cell carcinoma (OPSCC) cases are associated with human papillomavirus and favorable prognosis. Post-treatment follow-up should be targeted to patients at greatest risk for disease recurrence. To assess the benefits of routine clinical surveillance in OPSCC, we reviewed all follow-up visits conducted in 2014 at Helsinki University Hospital Department of Otorhinolaryngology. Of 366 visits, 26 (7%) were from patients presenting with a new symptom, and disease recurrence was detected in four. The presence of a new symptom was significantly associated with disease recurrence (P < 0.001). Of 366 visits, 340 (93%) were from patients presenting without new symptoms, and not a single recurrence was found during these visits. Based on our findings, and previous studies assessing the prognosis and pattern of recurrent OPSCC, we concluded that the number of routine post-treatment visits can be reduced. Follow-up should rather focus on symptom-directed examinations.
Sections du résumé
BACKGROUND
The majority of new oropharyngeal squamous cell carcinoma (OPSCC) cases are associated with human papillomavirus and favorable prognosis. Post-treatment follow-up should be targeted to patients at greatest risk for disease recurrence.
METHODS
To assess the benefits of routine clinical surveillance in OPSCC, we reviewed all follow-up visits conducted in 2014 at Helsinki University Hospital Department of Otorhinolaryngology.
RESULTS
Of 366 visits, 26 (7%) were from patients presenting with a new symptom, and disease recurrence was detected in four. The presence of a new symptom was significantly associated with disease recurrence (P < 0.001). Of 366 visits, 340 (93%) were from patients presenting without new symptoms, and not a single recurrence was found during these visits.
CONCLUSIONS
Based on our findings, and previous studies assessing the prognosis and pattern of recurrent OPSCC, we concluded that the number of routine post-treatment visits can be reduced. Follow-up should rather focus on symptom-directed examinations.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1457-1462Commentaires et corrections
Type : CommentIn
Type : CommentIn
Informations de copyright
© 2018 Wiley Periodicals, Inc.